Ryan J Marker1, Emily Cox-Martin2, Catherine M Jankowski3, W Thomas Purcell2, John C Peters4. 1. Department of Physical Therapy, School of Health Sciences and Human Performance, Ithaca College, Ithaca, NY, USA. rmarker@ithaca.edu. 2. Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 3. College of Nursing, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 4. Anschutz Health and Wellness Center, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Abstract
PURPOSE: Despite national recommendations, exercise programs are still not clinically implemented as standard of care for cancer survivors. This investigation examined the effects of a clinically implemented and personalized exercise program on physical fitness, fatigue, and depression in a diverse population of cancer survivors. The association of various participant characteristics on program performance was also examined. METHODS: Data were collected from 170 cancer survivors who had participated in a clinical exercise program. Any cancer type was included and survivors were either undergoing medical treatment or had completed treatment (< 6 months prior to program initiation). Baseline and post program measures of estimated VO2peak, grip strength, fatigue, and depression were compared in survivors who completed the program follow-up. Multiple regressions were performed to investigate the association of age, gender, body mass index (BMI), and medical treatment status on baseline and change scores in outcome measures, as well as program adherence. RESULTS: All measures improved in participants who completed the program (p < 0.01). Age, gender, and BMI were associated with baseline measures of estimated VO2peak and grip strength (p < 0.01), and age was inversely associated with baseline fatigue (p = 0.02). Only BMI was inversely associated with change in estimated VO2peak (p < 0.01). No participant characteristics or baseline measures were predictive of program adherence (p > 0.05). CONCLUSION: This investigation provides evidence that a personalized, clinical exercise program can be effective at improving physical fitness, fatigue, and depression in a diverse population of cancer survivors.
PURPOSE: Despite national recommendations, exercise programs are still not clinically implemented as standard of care for cancer survivors. This investigation examined the effects of a clinically implemented and personalized exercise program on physical fitness, fatigue, and depression in a diverse population of cancer survivors. The association of various participant characteristics on program performance was also examined. METHODS: Data were collected from 170 cancer survivors who had participated in a clinical exercise program. Any cancer type was included and survivors were either undergoing medical treatment or had completed treatment (< 6 months prior to program initiation). Baseline and post program measures of estimated VO2peak, grip strength, fatigue, and depression were compared in survivors who completed the program follow-up. Multiple regressions were performed to investigate the association of age, gender, body mass index (BMI), and medical treatment status on baseline and change scores in outcome measures, as well as program adherence. RESULTS: All measures improved in participants who completed the program (p < 0.01). Age, gender, and BMI were associated with baseline measures of estimated VO2peak and grip strength (p < 0.01), and age was inversely associated with baseline fatigue (p = 0.02). Only BMI was inversely associated with change in estimated VO2peak (p < 0.01). No participant characteristics or baseline measures were predictive of program adherence (p > 0.05). CONCLUSION: This investigation provides evidence that a personalized, clinical exercise program can be effective at improving physical fitness, fatigue, and depression in a diverse population of cancer survivors.
Authors: K Basen-Engquist; C Carmack; J Brown; A Jhingran; G Baum; J Song; S Scruggs; M C Swartz; M G Cox; K H Lu Journal: Gynecol Oncol Date: 2014-04 Impact factor: 5.482
Authors: Cheryl L Rock; Colleen Doyle; Wendy Demark-Wahnefried; Jeffrey Meyerhardt; Kerry S Courneya; Anna L Schwartz; Elisa V Bandera; Kathryn K Hamilton; Barbara Grant; Marji McCullough; Tim Byers; Ted Gansler Journal: CA Cancer J Clin Date: 2012-04-26 Impact factor: 508.702
Authors: Shiraz I Mishra; Roberta W Scherer; Claire Snyder; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu Journal: Cochrane Database Syst Rev Date: 2012-08-15
Authors: Irene Cantarero-Villanueva; Noelia Galiano-Castillo; Carolina Fernández-Lao; Lourdes Diaz-Rodríguez; Antonio Manuel Fernández-Pérez; María J Sánchez; Manuel Arroyo-Morales Journal: Clin Breast Cancer Date: 2014-11-20 Impact factor: 3.225
Authors: Anneli Elme; Meri Utriainen; Pirkko Kellokumpu-Lehtinen; Tiina Palva; Riitta Luoto; Riku Nikander; Riikka Huovinen; Hannu Kautiainen; Salme Järvenpää; Heidi M Penttinen; Leena Vehmanen; Anna-Stina Jääskeläinen; Johanna Ruohola; Carl Blomqvist; Tiina Saarto Journal: Anticancer Res Date: 2013-04 Impact factor: 2.480
Authors: Caroline S Kampshoff; Mai J M Chinapaw; Johannes Brug; Jos W R Twisk; Goof Schep; Marten R Nijziel; Willem van Mechelen; Laurien M Buffart Journal: BMC Med Date: 2015-10-29 Impact factor: 8.775
Authors: Ryan J Marker; Andrew J Kittelson; Catherine M Jankowski; Jared J Scorsone; John C Peters; W Thomas Purcell Journal: Rehabil Oncol Date: 2022-04
Authors: Kelley R Covington; Timothy Marshall; Grace Campbell; Grant R Williams; Jack B Fu; Tiffany D Kendig; Nancy Howe; Catherine M Alfano; Mackenzi Pergolotti Journal: Support Care Cancer Date: 2021-04-26 Impact factor: 3.603
Authors: Louise Czosnek; Justin Richards; Eva Zopf; Prue Cormie; Simon Rosenbaum; Nicole M Rankin Journal: BMC Cancer Date: 2021-05-30 Impact factor: 4.430
Authors: Emma L McGinnis; Laura Q Rogers; Christine A Fruhauf; Catherine M Jankowski; Mary E Crisafio; Heather J Leach Journal: Int J Environ Res Public Health Date: 2021-12-02 Impact factor: 3.390
Authors: Jordan T Lee; Chad W Wagoner; Stephanie A Sullivan; Dean J Amatuli; Kirsten A Nyrop; Erik D Hanson; Lee Stoner; Brian C Jensen; Hyman B Muss; Claudio L Battaglini Journal: World J Clin Oncol Date: 2021-06-24
Authors: Mary C Hidde; Heather J Leach; Ryan J Marker; John C Peters; W Thomas Purcell Journal: Integr Cancer Ther Date: 2020 Jan-Dec Impact factor: 3.279